Octagon Capital Advisors’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-441,600
| Closed | -$12.1M | – | 35 |
|
|
2024
Q4 | $12.1M | Sell |
441,600
-110,400
| -20% | -$3.03M | 1.99% | 20 |
|
|
2024
Q3 | $14.1M | Sell |
552,000
-138,000
| -20% | -$3.51M | 2.19% | 15 |
|
|
2024
Q2 | $17.5M | Hold |
690,000
| – | – | 2.75% | 10 |
|
|
2024
Q1 | $21.3M | Sell |
690,000
-16,800
| -2% | -$519K | 2.56% | 12 |
|
|
2023
Q4 | $28.5M | Sell |
706,800
-264,839
| -27% | -$10.7M | 4.57% | 6 |
|
|
2023
Q3 | $25.6M | Sell |
971,639
-247,561
| -20% | -$6.53M | 3.94% | 8 |
|
|
2023
Q2 | $21M | Sell |
1,219,200
-118,960
| -9% | -$2.05M | 2.92% | 9 |
|
|
2023
Q1 | $22.2M | Buy |
1,338,160
+404,417
| +43% | +$6.71M | 3.19% | 10 |
|
|
2022
Q4 | $7.12M | Hold |
933,743
| – | – | 1.11% | 20 |
|
|
2022
Q3 | $9.28M | Hold |
933,743
| – | – | 1.6% | 15 |
|
|
2022
Q2 | $8.48M | Sell |
933,743
-1,333,743
| -59% | -$12.1M | 2.26% | 9 |
|
|
2022
Q1 | $23M | Buy |
2,267,486
+500,000
| +28% | +$5.08M | 4.98% | 5 |
|
|
2021
Q4 | $29.5M | Buy |
1,767,486
+1,198,072
| +210% | +$20M | 5.74% | 5 |
|
|
2021
Q3 | $26.7M | Buy |
569,414
+188,486
| +49% | +$8.83M | 6.57% | 5 |
|
|
2021
Q2 | $23.2M | Buy |
+380,928
| New | +$23.2M | 4.81% | 4 |
|